 DERMADEX
|
GlaxoSmithKline Biopharma
|
| clobetasol |
Antieccematoso |
| cr.x 15 g | $23.060,99 | (30/04/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
PAMI PLAN MEDICAMENTOS DE USO EVENTUAL |
| OS $9.224,40 AF $13.836,59 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $4.998,62 AF $18.062,37 |
|
|
|
|
| ung.x 15 g | $21.854,67 | (30/04/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
PAMI PLAN MEDICAMENTOS DE USO EVENTUAL |
| OS $8.741,87 AF $13.112,80 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $4.998,62 AF $16.856,05 |
|
|
|
|
| cr.x 30 g | $45.225,11 | (30/04/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
PAMI PLAN MEDICAMENTOS DE USO EVENTUAL |
| OS $18.090,04 AF $27.135,07 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $5.928,25 AF $39.296,86 |
|
|
|
|
| ung.x 30 g | $41.886,55 | (30/04/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
PAMI PLAN MEDICAMENTOS DE USO EVENTUAL |
| OS $16.754,62 AF $25.131,93 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $5.928,25 AF $35.958,30 |
|
|
|
|
| |
